According to COSMOS Pharmaceutical's latest financial reports the company has $0.12 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-05-31 | $0.32 B | 12.37% |
2022-05-31 | $0.29 B | -41.69% |
2021-05-31 | $0.50 B | 3.61% |
2020-05-31 | $0.48 B | 178.2% |
2019-05-31 | $0.17 B | -12.73% |
2018-05-31 | $0.19 B | -20.33% |
2017-05-31 | $0.25 B | 1.64% |
2016-05-31 | $0.24 B | 64.04% |
2015-05-31 | $0.15 B | -28.24% |
2014-05-31 | $0.20 B | 32.86% |
2013-05-31 | $0.15 B | -34.92% |
2012-05-31 | $0.24 B | 5.59% |
2011-05-31 | $0.22 B | 29.88% |
2010-05-31 | $0.17 B | 19.86% |
2009-05-31 | $0.14 B | 53.03% |
2008-05-31 | $96.14 M | 71.38% |
2007-05-31 | $56.09 M | -31.22% |
2006-05-31 | $81.56 M | 27.98% |
2005-05-31 | $63.72 M |